Fingerprint
Dive into the research topics of 'A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically